Profile

Eurofins CDMO Alphora develops and manufactures small molecule and biologic drug substances and drug products “under one roof” in Mississauga, Ontario, Canada. Its small molecule capabilities include the development and manufacture of API's and HPAPI's, oral drug products and API solid-state R&D. Eurofins biologics capabilities include the development and manufacture of mAbs, proteins and ADC's, and Sterile Fill (2026). Established in 2003, its FDA, Health Canada, and Japan PMDA inspected site has over 250 people.


Event details

Date: December 1 - 5, 2025

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences

Participants

13 in total